  Osimertinib , a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor , exerts remarkable effects against We prospectively evaluated the sensitivity , specificity , and parallelism of the detection of Fifteen patients were enrolled. In 10 patients whose Plasma , serum , and tissue genotyping can have complementary roles for detecting